Trial Search
Current Search Criteria:
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PHASE3The purpose of the study is to evaluate efficacy of riliprubart compared to...
Status
Recruiting
Location
Alabama Neurology Associates- Site Number : 8400019
Start Date
2024-08-21
Trial ID
NCT06290141
Treatments Being Tested
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
N/ACIDP and MMN are part of a group of chronic inflammatory conditions that af...
Status
Completed
Location
The Walton Centre NHS Foundation Trust
Start Date
2020-09-28
Trial ID
NCT04356781
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NAParticipants will be requested to deliver non-invasive vagus nerve stimulat...
Status
Terminated
Location
Children's Healthcare of Atlanta, Center for Advanced Pediatrics
Start Date
2022-02-22
Trial ID
NCT03772717
Treatments Being Tested
Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
N/AThis study aims analyze the transcriptome to identify predictive biomarkers...
Status
Completed
Location
CHU Bordeaux, service de Neurologie
Start Date
2014-04-16
Trial ID
NCT02629796
Treatments Being Tested
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PHASE2This is a randomized controlled study evaluating safety and efficacy of rep...
Status
Recruiting
Location
Department of Neurology, University of Ulm
Start Date
2023-05-01
Trial ID
NCT04881682
Treatments Being Tested
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/AThe main aim of this study is to evaluate the rates of adverse events of sp...
Status
Completed
Location
RTI Health Solutions
Start Date
2022-05-27
Trial ID
NCT05363358
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
N/AThe goal of this observational study is to learn about chronic inflammatory...
Status
Terminated
Location
Peltier Amanda
Start Date
2023-02-28
Trial ID
NCT05614128
Treatments Being Tested
IVIG vs SCIG in CIDP
PHASE1Current dosing practices for immunoglobulin G (IgG) may be inadequate in ex...
Status
Recruiting
Location
Rutgers, The State University of New Jersey Clinical Research Center
Start Date
2022-09-11
Trial ID
NCT05584631
Treatments Being Tested
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
PHASE4SIDEC - (Subcutaneous Immunoglobulin in De-novo CIDP) ia a study designed a...
Status
Recruiting
Location
Department of Neurology, Aalborg University Hospital
Start Date
2020-06-04
Trial ID
NCT04589299
Treatments Being Tested
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
PHASE3The main aim of this study is to evaluate the pharmacokinetic (PK) comparab...
Status
Recruiting
Location
HonorHealth Neurology
Start Date
2025-05-06
Trial ID
NCT06747351
Treatments Being Tested